EARLY WARNING NEWS RELEASE OF MARNY S.A. PROVIDING UPDATE TO OPTION AGREEMENT WITH ANDREW BENEDEK

LUXEMBOURG, Sept. 30, 2026 /CNW/ -- On August 11, 2026, Marny S.A. ("Marny") announced that it had entered into share option agreement with Dr. Andrew Benedek ("Benedek") dated August 11, 2026 (the "Option Agreement") pursuant to which Benedek granted to Marny an option (the "Option"), subject to certain terms and conditions, to acquire up to 32,988,232 of the common shares (the "Shares") of Anaergia Inc. ("Anaergia") (such Shares subject to the Option, the "Optioned Shares") at a price of C$3.00 per Share.

In accordance with the terms of the Option Agreement, the term of the Option has been automatically extended until the earlier of (i) five business days after the date on which the Company's interim financial statements and management's discussion and analysis for the period ended September 30, 2026 are filed on SEDAR+, and (ii) November 20, 2026. All other terms and conditions of the Option Agreement remain as previously disclosed on the August 11, 2026 press release and early warning report.

As of the date of this press release, Marny's has ownership or control over (a) 100,208,520 Shares (including 263,520 Shares held by Ohad Epschtein and 6,800,000 Shares held by Ronen Kantor), representing approximately 58.11% of the issued and outstanding Shares on a non-diluted basis, (b) 18,360,000 common share purchase warrants of Anaergia (the "Warrants") and (c) 333,333 restricted share units of Anaergia (the "RSUs"). If the Warrants, the RSUs and the Option are exercised in full, Marny would have ownership or control over 151,890,085 Shares, representing approximately 79.46% of the issued and outstanding Shares on a partially diluted basis.

As previously disclosed on the August 11, 2026 press release and early warning report, Marny entered into the Option Agreement and is acquiring the Shares for investment purposes. Marny may, from time to time, acquire additional Shares or other securities of Anaergia, or dispose of some or all of the Shares or other securities of Anaergia that it owns from time to time, subject to market conditions and other relevant factors.

Marny currently has no plans or intentions that relate to or would result in any of the actions listed in items (a) to (k) in the early warning reports filed by Marny with this press release (the "Early Warning Reports"). However, depending on market conditions, general economic and industry conditions, trading prices of Anaergia's securities, Anaergia's business, financial condition and prospects, and/or other relevant factors Marny may develop such plans or intentions in the future.

The head office of Anaergia is located at 4210 South Service Road, Burlington, Ontario L7L 4X5.

For further information, please refer to the Early Warning Reports that are to be posted on the SEDAR+ profile of Anaergia at www.sedarplus.ca, or that may be obtained from:

Marny S.A.
Lukasz Motyl, Sole Director
26, Boulevard Grand-Duchesse Charlotte, L-1330 Luxembourg, [phone]

SOURCE Marny S.A.